Schedule 13G ownership disclosure

PIERIS PHARMACEUTICALS INC

Security class unavailable · CUSIP: 720795103

Event date: 2022-10-13

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
3,824,619
Percent of class
5.1000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000902664-22-004631
Form type
SC 13G
Filer
Lynx1 Capital Management LP
CIK
CIK 1910456
Filed
Oct 24, 2022
Reporting period
Oct 13, 2022
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub